Is Genomic Risk Stratification useful for Patients with early HR+/ERBB2 Breast Cancer?

被引：0
|
作者：
Lichert, Frank
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：474 / 474
页数：1
相关论文
共 50 条
  • [1] Heritable Variation of ERBB2 and Breast Cancer Risk
    Breyer, Joan P.
    Sanders, Melinda E.
    Airey, David C.
    Cai, Qiuyin
    Yaspan, Brian L.
    Schuyler, Peggy A.
    Dai, Qi
    Boulos, Fouad
    Olivares, Maria G.
    Bradley, Kevin M.
    Gao, Yu-Tang
    Page, David L.
    Dupont, William D.
    Zheng, Wei
    Smith, Jeffrey R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) : 1252 - 1258
  • [2] Clinical and genomic landscape of ERBB2 and ERBB3 mutated breast cancer
    Bilani, Nadeem
    Tao, Jacqueline
    Safonov, Anton
    Casey, Dana
    Drago, Joshua
    Ahmed, Mehnaj
    Acevedo, Barbara
    Jhaveri, Komal
    Reis-Filho, Jorge
    Robson, Mark
    Toska, Eneda
    Hanker, Ariella
    Arteaga, Carlos
    Chandarlapaty, Sarat
    Wen, Hanna Y.
    Razavi, Pedram
    CANCER RESEARCH, 2024, 84 (09)
  • [3] Complex genomic regions associated with ERBB2 amplification in breast cancer
    Tanaka, Hisashi
    Marotta, Michael
    Tubbs, Raymond R.
    CANCER RESEARCH, 2012, 72
  • [4] Tumour stroma characterization for the clinical stratification of HR+/HER2-breast cancer
    Scatena, C.
    Fanelli, G. N.
    Belcastro, E.
    Di Cocco, F.
    Fontana, A.
    Szumera-Cieckiewicz, A.
    Loda, M.
    Naccarato, A. G.
    VIRCHOWS ARCHIV, 2024, 485 : S5 - S5
  • [5] Risk Stratification of Patients With Early Breast Cancer
    Roy, Pankaj Gupta
    Chan, Suet M.
    Ng, Vivien
    Smith, Brendan M.
    Umeh, Hilary
    Courtney, Stephen P.
    CLINICAL BREAST CANCER, 2014, 14 (01) : 68 - 73
  • [6] Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
    Carausu, Marcela
    Carton, Matthieu
    Dieras, Veronique
    Petit, Thierry
    Guiu, Severine
    Goncalves, Anthony
    Augereau, Paule
    Ferrero, Jean Marc
    Levy, Christelle
    Ung, Mony
    Desmoulins, Isabelle
    Debled, Marc
    Bachelot, Thomas
    Pistilli, Barbara
    Frenel, Jean-Sebastien
    Mailliez, Audrey
    Chevrot, Michael
    Cabel, Luc
    JAMA NETWORK OPEN, 2022, 5 (12) : E2247154
  • [7] Multi-country study of the use of genomic assays in HR+, HER2-early breast cancer and characteristics of patients tested
    Brown, Jacqueline
    Williams, Rhys
    Rider, Alex
    Wild, Rosie
    Method, Michael
    CANCER RESEARCH, 2021, 81 (04)
  • [8] Role of erbB2 in breast cancer chemosensitivity
    Yu, DH
    Hung, MC
    BIOESSAYS, 2000, 22 (07) : 673 - 680
  • [9] Multimodal integration using a machine learning approach facilitates risk stratification in HR+/HER2-breast cancer
    Zhang, Hang
    Yang, Fan
    Xu, Ying
    Zhao, Shen
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    Xiao, Yi
    CELL REPORTS MEDICINE, 2025, 6 (02)
  • [10] ErbB2 diagnostics in breast cancer - an update
    Rueschoff, J.
    Nagelmeier, I.
    Hofmann, M.
    Henkel, Th.
    Stoss, O.
    PATHOLOGE, 2009, 30 (02): : 147 - 155
12345